Matches in Nanopublications for { ?s ?p "[In the meta-analysis data, MAP2K5 was associated with inattention, GPRC5B with hyperactivity/impulsivity and inattention and CADM2 with hyperactivity/impulsivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- assertion description "[In the meta-analysis data, MAP2K5 was associated with inattention, GPRC5B with hyperactivity/impulsivity and inattention and CADM2 with hyperactivity/impulsivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In the meta-analysis data, MAP2K5 was associated with inattention, GPRC5B with hyperactivity/impulsivity and inattention and CADM2 with hyperactivity/impulsivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In the meta-analysis data, MAP2K5 was associated with inattention, GPRC5B with hyperactivity/impulsivity and inattention and CADM2 with hyperactivity/impulsivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In the meta-analysis data, MAP2K5 was associated with inattention, GPRC5B with hyperactivity/impulsivity and inattention and CADM2 with hyperactivity/impulsivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1063940.RAQ4ZAy7rmAAPWkQBuVbhry35CEBwxIzu-D-T4xfURBFE130_assertion description "[In the meta-analysis data, MAP2K5 was associated with inattention, GPRC5B with hyperactivity/impulsivity and inattention and CADM2 with hyperactivity/impulsivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1063940.RAQ4ZAy7rmAAPWkQBuVbhry35CEBwxIzu-D-T4xfURBFE130_provenance.
- assertion description "[In the meta-analysis data, MAP2K5 was associated with inattention, GPRC5B with hyperactivity/impulsivity and inattention and CADM2 with hyperactivity/impulsivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In the meta-analysis data, MAP2K5 was associated with inattention, GPRC5B with hyperactivity/impulsivity and inattention and CADM2 with hyperactivity/impulsivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP646107.RAtqJYf3reMuSyFTm20ciGjQkQP_1bM__j5dfNDL2qWN4130_assertion description "[In the meta-analysis data, MAP2K5 was associated with inattention, GPRC5B with hyperactivity/impulsivity and inattention and CADM2 with hyperactivity/impulsivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646107.RAtqJYf3reMuSyFTm20ciGjQkQP_1bM__j5dfNDL2qWN4130_provenance.
- NP907642.RAtPX2y0-9xGg2b9Xg8eG1yDweQhZo_aBdY1rqgynDZ4A130_assertion description "[In the meta-analysis data, MAP2K5 was associated with inattention, GPRC5B with hyperactivity/impulsivity and inattention and CADM2 with hyperactivity/impulsivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP907642.RAtPX2y0-9xGg2b9Xg8eG1yDweQhZo_aBdY1rqgynDZ4A130_provenance.
- NP981600.RAkRh39SbFZIvnVlImiViDQuTBZtpOhO5jE0JrTXxez5s130_assertion description "[In the meta-analysis data, MAP2K5 was associated with inattention, GPRC5B with hyperactivity/impulsivity and inattention and CADM2 with hyperactivity/impulsivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP981600.RAkRh39SbFZIvnVlImiViDQuTBZtpOhO5jE0JrTXxez5s130_provenance.
- NP1063942.RAmGa-RjITyaxsOld7f8DZcozXsEIjOTUYsjaNk2fiXJ0130_assertion description "[In the meta-analysis data, MAP2K5 was associated with inattention, GPRC5B with hyperactivity/impulsivity and inattention and CADM2 with hyperactivity/impulsivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1063942.RAmGa-RjITyaxsOld7f8DZcozXsEIjOTUYsjaNk2fiXJ0130_provenance.
- NP1063943.RA8xk6LuS4XaBnLlGm848UM3-rEKNMa5HH3jsm3TydipI130_assertion description "[In the meta-analysis data, MAP2K5 was associated with inattention, GPRC5B with hyperactivity/impulsivity and inattention and CADM2 with hyperactivity/impulsivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1063943.RA8xk6LuS4XaBnLlGm848UM3-rEKNMa5HH3jsm3TydipI130_provenance.